A new program for store supervisors and department managers may make them better employees but may not help them reach the middle class.
NYS Entity Status
NYS Filing Date
AUGUST 29, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2013 - FOURWINDS CAPITAL MANAGEMENT (US) INC.
AROUND THE WEB
- At Walmart Academy, Training Better Managers. But With a Better Future?
By MICHAEL CORKERY - Tuesday Aug 8, 2017
- Martin Shkreli is found guilty of fraud
By Stephanie Clifford and Colin Moynihan - Friday Aug 4, 2017
NEW YORK — Martin Shkreli, accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts on Friday, after a five-week trial in U.S. District Court in Brooklyn, N.Y.Shkreli was accused of securities and wire fraud related to two hedge funds he ran, MSMB Capital and MSMB Healthcare.The prosecution brought forth an “avalanche” of evidence, as prosecutor Jacquelyn Kasulis put it in her rebuttal argument, that included a threatening letter he sent to the wife of a former employee, statements he sent to MSMB investors showing great returns at the same time he had no money in fund accounts, three versions of a backdated agreement to make it look as if MSMB Capital had invested in Retrophin when it had not, as well as claims about assets under management that were wildly out of line with his actual fund size.
- Toast Devours $101M for Restaurant Tech, Plans to Hire 1,000
By Jeff Engel - Tuesday Jul 25, 2017
Toast, the fast-growing restaurant technology company, has just been served a heaping portion of venture capital to continue expanding. On Tuesday, the Boston-based company announced a $101 million investment led by new backers Generation Investment Management—whose co-founder and chairman is former Vice President Al Gore—and Lead Edge Capital. Bessemer Venture Partners and other earlier Toast […]
- Atlas Venture Unveils New $350M Fund for Seed Biotech Investments
By Frank Vinluan - Thursday Jun 29, 2017
Life sciences venture capital firm Atlas Venture now has $350 million in fresh capital to invest in the early stage biotech companies in the U.S. and around the world. The new fund is Cambridge, MA-based Atlas’ eleventh. Atlas partner Bruce Booth says in a blog post that the firm began raising funds in April, bringing […]
- Common Sense: As a Guru, Ayn Rand May Have Limits. Ask Travis Kalanick.
By JAMES B. STEWART - Thursday Jul 13, 2017
For all the influence of the Objectivist principles set forth in “The Fountainhead” and other works, some prominent followers have run into trouble.
- The Strange Case of Martin Shkreli Is Wrapping Up
By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017
An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.